Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CYTH3 |
| Upstream (Parents) |
|---|
| (<<) CTRB2 → CYTH3 |
| (<<) SUN1 → CYTH3 |
| (<<) GRM1 → CYTH3 |
| (<<) PTP4A3 → CYTH3 |
| (<<) HIST1H2AH///HIST1H2AG///HIST1H2AM///HIST1H2AL///HIST1H2AJ///HIST1H2AK///HIST1H2AI → CYTH3 |
| (<<) TBC1D8 → CYTH3 |
| Downstream (Children) |
|---|
| CYTH3 → CTRB2 (>>) |
| CYTH3 → GRM1 (>>) |
| CYTH3 → PRAME (>>) |
| CYTH3 → KDSR (>>) |
| CYTH3 → SEMG2 (>>) |
| CYTH3 → MYO5A (>>) |
| CYTH3 → LOC100129973 (>>) |
| CYTH3 → HRASLS2 (>>) |
| CYTH3 → TOX (>>) |
| CYTH3 → STX2 (>>) |
| CYTH3 → C22orf36 (>>) |
| CYTH3 → PTENP1 (>>) |
| CYTH3 → ODF1 (>>) |
